Skip to content

A Study to Evaluate the Effect of Brihatyadi Kashaya and Sahacharadi Kashaya Enema Therapy in the Management of Female Infertility

A Randomised Open-Labeled Comparative Clinical Study to Evaluate the Efficacy of Brihatyadi Yapana Basti and Sahacharadi Yapana Basti in the Management of Stree Vandhyatwa with Special Reference to Aberrant Folliculogenesis - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086749
Enrollment
30
Registered
2025-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z318- Encounter for other procreative management

Interventions

None listed

Sponsors

Dr Chetana Patil
Lead Sponsor
SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Married women of age between 20 to 40 years. Subject with the features of Vandhyatwa. Subject of Primary or Secondary Infertility. Subject with the history of regular menstruation. Subject with the history of Anovulation. Subject with the history of PCOD, Hypomenorrhea, Menorrhagia, and Fibroid uterus. Subject with the history of Habitual abortion, Spontaneous abortion, or Recurrent abortion.

Exclusion criteria

Exclusion criteria: Subjects with a history of Pelvic Inflammatory Disease (PID), Endometriosis, and Tubal occlusion Subjects with any known case of benign and malignant tumors Subjects with any known case of Polymenorrhea, Metrorrhagia, or Menometrorrhagia Subjects who are not eligible (Ayogya) for Basti treatment Subjects with hemoglobin percentage less than eight grams per deciliter Systemic diseases which interfere with the course of treatment Subjects who are not willing to give consent for the treatment

Design outcomes

Primary

MeasureTime frame
Significant growth of Graafian follicle, ovulation followed by conception in Stree Vandhyatva with special reference to Aberrant folliculogenesis based on assessment criteria. Follicular study performed before and after the treatment. Efficacy of medicine assessed based on the size of the follicle. Efficacy of medicine assessed based on Ovulation. Timepoint: After 8-10 weeks

Secondary

MeasureTime frame
Generation of in- depth analyzed data on the different aspect of the disease. Generation of data on possible unexpected drug reaction. Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Chetana Patil

Sri Sri College of Ayurvedic Science and Research Hospital, Bengaluru

dr.rachanabhat@gmail.com9535744077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026